Kazia Therapeutics (KZIA) Change in Working Capital (2021 - 2022)
Kazia Therapeutics (KZIA) posted Change in Working Capital of -$427164.7 for Q4 2022, up 64.33% on a QoQ basis from -$1.2 million in Q4 2021, and up 64.33% year-over-year from -$259938.6 in Q4 2021.
Kazia Therapeutics (KZIA) Change in Working Capital (2021 - 2022) Analysis & Trends
Kazia Therapeutics' Change in Working Capital history runs 2 years deep, the most recent figure standing at -$427164.7 for Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -427,164.70 |
| Dec 31, 2022 | -427,164.70 |
| Dec 31, 2021 | -1.20 Mn |
| Dec 31, 2021 | -1.20 Mn |